欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NO/H/0218/002
药品名称Cefuroxim IPP 1500 mg
活性成分
    • cefuroxime sodium salt 1500.0 mg
剂型Powder for solution for infusion/injection
上市许可持有人IPP International Pharma Partners GmbH Marienplatz 10-12 D- 94081 Fürstenzell Germany
参考成员国 - 产品名称Norway (NO)
Cefuroxim IPP
互认成员国 - 产品名称
    • Estonia (EE)
      CEFUROXIME MIP 1500 MG
    • Hungary (HU)
      CEFUROXIM MIP 1500 mg por oldatos injekcióhoz
    • Germany (DE)
      Cefuroxim IPP 1500 mg
    • Denmark (DK)
    • United Kingdom (Northern Ireland) (XI)
    • Sweden (SE)
    • Finland (FI)
    • Lithuania (LT)
      Cefuroxime IPP 1500 mg milteliai injekciniam arba infuziniam tirpalui
许可日期2012/12/18
最近更新日期2023/05/22
药物ATC编码
    • J01DC02 cefuroxime
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase